Overexpression of periostin predicts poor prognosis in non-small cell lung cancer

By        

Oncology Letters, Vol. 6, Iss. 6, 2013-01 ,pp. : 1595-1603

Spandidos Publications

Access to resources Recommend Favorite

High circulating miR‐18a, miR‐20a, and miR‐92a expression correlates with poor prognosis in patients with non‐small cell lung cancer

By  

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 21-31

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC)

By Monnet I.   Brienza S.   Hugret F.   Voisin S.   Gastiaburu J.   Saltiel J.C.   Soulie P.   Armand J.P.   Cvitkovic E.   de Cremoux H.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1124-1127

Elsevier

Access to resources Recommend Favorite

The CRP 1846T/T genotype is associated with a poor prognosis in patients with non-small cell lung cancer

By Minamiya Yoshihiro  

Tumor Biology, Vol. 31, Iss. 6, 2010-12 ,pp. : 673-679

Springer Publishing Company

Access to resources Recommend Favorite

High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer

By Zhou Hui   Chen Jian-hua   Hu Jun   Luo Yong-zhong   Li Fang   Xiao Ling   Zhong Mei-zuo  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 4, 2014-04 ,pp. : 633-643

Springer Publishing Company

Access to resources Recommend Favorite